LABELING AND DETECTION OF ASC SPECKS

ASTROCYTE TRAUMATOME AND NEUROTRAUMA BIOMARKERS

METHODS AND SYSTEMS FOR RAPID DETECTION OF STROKE AND DETERMINATION OF ONSET VIA NEUROINFLAMMATION BIOMARKERS

Method of Determining Risk for Chronic Stress and Stroke

METHODS FOR AIDING IN DIAGNOSING AND EVALUATING A TRAUMATIC BRAIN INJURY IN A HUMAN SUBJECT USING A COMBINATION OF GFAP AND UCH-L1

PROTEIN MARKER PANEL FOR SCREENING CLINICAL FUTILE RECANALIZATION (FR) IN LARGE VESSEL OCCLUSION-INDUCED ACUTE ISCHEMIC STROKE (LVO-AIS) AND USE THEREOF

MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME

ASSAYS AND METHODS OF USE OF THOSE ASSAYS IN THE CARE AND DIAGNOSIS OF STROKE PATIENTS

MICROENVIRONMENTAL DETERMINANTS OF CLONAL HEMATOPOIESIS EXPANSION RATE

Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases

METHODS FOR DETECTING AND TREATING CEREBRAL CAVERNOUS MALFORMATION

BIOMARKERS FOR SEVERITY OF ISCHEMIC STROKE AND USE THEREOF

ATF3 AS A BIOMARKER OF CENTRAL NERVOUS SYSTEM INJURY

ANIMAL, FUNGAL AND MARINE SOURCES OF CGP AND INCREASED CGP CONCENTRATION FOR DISEASE MANAGEMENT AND FOR TREATMENT OF NON-NEUROLOGICAL AND/OR NEUROLOGICAL CONDITIONS

Biomarkers For Detecting Human Glycogen Phosphorylase Isoenzyme BB

METHODS FOR AIDING IN THE DIAGNOSIS AND EVALUATION OF A SUBJECT WHO HAS SUSTAINED AN ORTHOPEDIC INJURY AND THAT HAS OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD, SUCH AS MILD TRAUMATIC BRAIN INJURY (TBI), USING GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND/OR UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1)

METABOLOMIC PROFILES FOR PREDICTION OF FUNCTIONAL NEUROLOGICAL OUTCOME OR DEATH FOLLOWING SEVERE TRAUMATIC BRAIN INJURY

MULTI-ARRAY IMPEDIMETRIC BIOSENSORS FOR THE DETECTION OF CONCUSSION AND TRAUMATIC BRAIN INJURIES

METHODS AND DEVICES FOR DETECTING CEREBROSPINAL FLUID LEAKAGE

SYSTEMS AND METHODS FOR DETERMINING UCH-L1, GFAP, AND OTHER BIOMARKERS IN BLOOD SAMPLES

IMMOBILIZED PROTEIN SYSTEM FOR RAPID AND ENHANCED MULTIPLEXED DIAGNOSTICS

Cardiovascular Disease

BIOMARKER DETECTION PROCESS AND ASSAY OF NEUROLOGICAL CONDITION

METHOD FOR ASSESSING RISK OF HEMORRHAGIC STROKE USING SOLUBLE CLEC2

METHOD FOR EVALUATING RISK OF ACUTE CEREBRAL VASCULAR DISEASE USING SOLUBLE CLEC2

Biomarkers for the Detection of Thrombosis or Coagulation-Related Disorders and Their Applications

Cilia Protein as Biomarkers and Methods of Use

METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT’S RECOVERY FROM A BRAIN INJURY RESULTING FROM A HYPOXIC EVENT

MARKERS FOR THE DIAGNOSIS OF LARGE VESSEL OCCLUSION

HUMORAL ANTIBODY BIOMARKER FOR DETECTING ARTERY LESIONS, AND DETECTING CEREBROVASCULAR AND CARDIOVASCULAR DISORDER, DIABETES, CHRONIC NEPHROPATHY, OR SOLID CANCER

MAGNETIC POINT-OF-CARE SYSTEMS AND ASSAYS FOR DETERMINING GFAP IN BIOLOGICAL SAMPLES

METHOD OF TREATING LARGE VESSEL OCCLUSION STROKE

BLOOD BIOMARKER THAT PREDICTS PERSISTENT COGNITIVE DYSFUNCTION AFTER CONCUSSION

METHODS FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER DURING CEREBRAL ISCHEMIC STROKE AND APPLICATION THEREOF

ESM-1 FOR THE ASSESSMENT OF SILENT BRAIN INFARCTS AND COGNITIVE DECLINE

METHOD FOR DIAGNOSING STROKE UTILIZING GENE EXPRESSION SIGNATURES

METHODS FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF

MULTIMARKER PANEL FOR THE ASSESSMENT OF SILENT BRAIN INFARCTS AND COGNITIVE DECLINE

IMMOBILIZED PROTEIN SYSTEM FOR RAPID AND ENHANCED MULTIPLEXED DIAGNOSTICS

SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA

METHODS AND SYSTEMS OF DIAGNOSING BRAIN INJURY

METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS

BIOFLUID-BASED PROTEIN AND MIRNA BIOMARKERS FOR NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY

Identifying Risk of Cerebra Edema

RET (REARRANGED DURING TRANSFECTION) FOR THE ASSESSMENT OF STROKE

DEVICES AND METHODS FOR TREATING ISCHAEMIA AND ACUTE RESPIRATORY DISTRESS SYNDROMES

Methods, Systems, and a Kit for Diagnosis, Detection, Monitoring & Treatment of Traumatic Brain Injury

Blood biomarkers and diagnostic methods for small vessel diseases

MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME

Method of treating large vessel occlusion stroke

THERANOSTICS FOR HYPERTENSION INDUCED MYOCARDIAL MICROBLEEDS

METHOD FOR SELECTING A PATIENT FOR A REPERFUSION THERAPY

DETECTION OF AUTOANTIBODIES AGAINST DEIMINATED PROTEIN EPITOPES ASSOCIATED WITH BRAIN OXYGEN DEPRIVATION

ASTROCYTE TRAUMATOME AND NEUROTRAUMA BIOMARKERS

Method of Determining Risk for Chronic Stress and Stroke

BIOMARKER FOR DIAGNOSIS OF CEREBRAL NERVOUS SYSTEM DISEASES

COMPOSITIONS AND METHODS FOR TREATING CEREBRAL VASOSPASM

THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA

MULTI-LAYERED FILTER FOR SEPARATING BLOOD COMPONENTS AND DISEASE DIAGNOSIS KIT USING THE SAME

PERIPHERAL BLOOD MARKER FOR CERABRAL HEMORRHAGE AND APPLICATION THEREOF

In vitro method for diagnosing central nervous system injury

Marker for diagnosing atherosclerosis severity, and diagnostic method using same

Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1

OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

BODY FLUID ANTIBODY BIOMARKER FOR HIGHLY SENSITIVE DETECTION OF RISK OF ONSET OF CEREBRAL INFARCTION

Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)

METHODS AND COMPOSITIONS FOR TREATING A BRAIN INJURY

COMPOSITIONS AND METHODS FOR TARGETED CONTRAST AGENTS FOR MOLECULAR IMAGING

METHOD AND APPARATUS FOR PREDICITING NEUROLOGICAL OUTCOME POST-CARDIAC ARREST

CIRCULATING FGFBP-1 (FIBROBLAST GROWTH FACTOR-BINDING PRO-TEIN 1) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND FOR THE PREDICTION OF STROKE

CIRCULATING SPON-1 (SPONDIN-1) IN THE ASSESSMENT OF ATRIAL FIBRILLATION

CIRCULATING TFPI-2 (TISSUE FACTOR PATHWAY INHIBITOR 2) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND ANTICOAGULATION THERAPY

ISOLATING AND ANALYZING RARE BRAIN-DERIVED CELLS AND PARTICLES

Decision support tool for stroke patients

CIRCULATING DKK3 (DICKKOPF-RELATED PROTEIN 3) IN THE ASSESSMENT OF ATRIAL FIBRILLATION

USE OF GFAP FOR IDENTIFICATION OF INTRACEREBRAL HEMORRHAGE

Mild Traumatic Brain Injury Diagnostic Immunochromatographic Microneedle Patch

Nanovesicles derived from bacteria of genus and use thereof

NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY SEVERITY DETERMINING METHOD AND PROGNOSIS PREDICTING METHOD

Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening

ANTIBODY FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF

Biomarker detection process and assay of neurological condition

COMPUTER IMPLEMENTED DISCOVERY OF ANTIBODY SIGNATURES

ANTIBODY FOR DETECTING EARLY DAMAGE TO BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND USE THEREOF

ANTIBODY FOR USE IN DETECTING EARLY-STAGE DAMAGE OF BLOOD BRAIN BARRIER DURING CEREBRAL ISCHEMIC STROKE AND APPLICATION THEREOF

METHODS OF ASSESSING FUTURE MEMORY LOSS BY MEASURING POLYUNSATURATED FATTY ACIDS

METHODS AND COMPOSITIONS FOR TREATING A BRAIN INJURY

NT-proANP AND NT-proBNP FOR THE DIAGNOSIS OF STROKE

METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS

Astrocyte traumatome and neurotrauma biomarkers

ALPHA-B CRYSTALLIN IN THE DIAGNOSIS OF NEONATAL BRAIN DAMAGE

PREDICTION METHOD FOR RISK OF ISCHEMIC STROKE ONSET

DETECTION OF HIGH RISK ARTERIAL THROMBOEMBOLIC DISEASES BY MARKERS OF COAGULATION AND HEMOSTATIC ACTIVATION

Therapy for subarachnoid hemorrhage and ischemia

Multi-protein biomarker assay for brain injury detection and outcome

BLOOD BIOMARKERS AND DIAGNOSTIC METHODS FOR SMALL VESSEL DISEASES

SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA

FASTING LEVELS OF GROWTH HORMONE AS A PREDICTIVE MARKER OF CARDIOVASCULAR RISK

Hough transform-based vascular network disorder features on baseline fluorescein angiography scans predict response to anti-VEGF therapy in diabetic macular edema

Identification and analysis of protein biomarkers

SYNTHETIC BLOOD VESSELS AND USES THEREOF

Biomarkers for the diagnosis of lacunar stroke

Detection of Brain Injury or Neurological Disease using Tau Protein

GFAP ACCUMULATING IN STROKE

Multi-array impedimetric biosensors for the detection of concussion and traumatic brain injuries

Decision support tool for stroke patients

GFAP DERIVATIVES FOR STROKE DIAGNOSTICS

Circulating astrocytes and MFSD2A as biomarkers

Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)

Procalcitonin for the prognosis of adverse events

Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1

Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes

Diagnostic reagent kit for detecting chronic brain pathologies of ischemic genesis

CIRCULATING ESM-1 (ENDOCAN) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND/OR STROKE

METHODS AND KITS FOR DIAGNOSING AND TREATING NERVOUS SYSTEM DISEASE OR INJURY

Methods and kits for the diagnosis and risk stratification of patients with ischemia

COMPOSITIONS AND METHODS FOR TARGETED CONTRAST AGENTS FOR MOLECULAR IMAGING

Ceramides for evaluating risk of cardiovascular disease

METHODS OF TREATING STROKE

OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

USE OF CERAMIDES AND LPLs IN DIAGNOSING CVD

Mobilization of pluripotent stem cells for ischemic cerebral infarction

BIOMARKERS FOR STROKE

Astrocyte traumatome and neurotrauma biomarkers

Platelet biomarkers and diagnostic methods for vascular diseases

Molecules in the tryptophan-5-hydroxytryptophan-serotonin-NAS-melatonin/6-hydroxymelatonin sulfate-melatonin receptor 1A pathway in neurological diseases

Synthetic blood vessels and uses thereof

PANEL OF ACVS-ASSOCIATED PROTEINS FOR DIAGNOSIS AND PROGNOSIS

Apparatus and Method to Determine Stroke Subtype

Circulating astrocytes and MFSD2A as biomarkers

Methods of distinguishing ischemic stroke from intracerebral hemorrhage

Endothelial cell derived exosomes and uses thereof

IL1RL-1 as a cardiovascular disease marker and therapeutic target

SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion

Method for treatment of traumatic brain injury targeting aggregated peptides

Methods of assessing future memory loss by measuring polyunsaturated fatty acids

Methods and devices to detect stroke in a subject

METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE

METHODS OF ASSESSING GFAP STATUS IN PATIENT SAMPLES

KITS FOR INDENTIFYING AND TREATING SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID

Metabolomics profiling of central nervous system injury

BIOMARKER DETECTION PROCESS AND ASSAY OF NEUROLOGICAL CONDITION

Method of treating neurological conditions with oleandrin

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF STROKE OR OTHER CEREBRAL INJURY

CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN

Methods for differentiating ischemic stroke from hemorrhagic stroke

METHODS AND KITS FOR DETECTING AND DIAGNOSING NEUROTRAUMA

Method for Detection of Ischemic Strokes

EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS

Blood biomarker for early blood brain barrier disruption in ischemic stroke

Biomarker-based methods for aiding the diagnosis of stroke

NEURAL SPECIFIC S100-BETA FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION

Use of ceramides and LPLs in diagnosing CVD

Method for detecting GABAA receptor autoantibodies

Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening

Immobilized protein system for rapid and enhanced multiplexed diagnostics

BIOMARKERS FOR SENSITIVE DETECTION OF STATIN-INDUCED MUSCLE TOXICITY

Biomarkers for diagnosing ischemia

Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes

USE OF ORP FOR CHARACTERIZING STROKE PATIENTS

Biomarkers for the diagnosis of lacunar stroke

Biomarkers for diagnosis of stroke and its causes

Method of treating neurological conditions with oleandrin

Biomarkers for diagnosis of transient ischemic attacks

Therapy for subarachnoid hemorrhage and ischemia

Assay for nitrated and total hemopexin in fluid samples

Decision support tool for stroke patients

Multi-protein biomarker assay for brain injury detection and outcome

Method for aiding differential diagnosis of stroke

BIOMARKERS FOR STROKE DIAGNOSIS

Biomarker for detecting white matter stroke, containing toll-like receptor 2, and medical use of toll-like receptor 2

Blood biomarker that predicts persistent cognitive dysfunction after concussion

Use of lymphocyte activation gene 3 (LAG-3) expression profiling as a biomarker for assessing inflammasomes, chronic inflammatory diseases and dysfunctional HDL

FASTING LEVELS OF GROWTH HORMONE AS A PREDICTIVE MARKER OF CARDIOVASCULAR RISK

Biomarkers for rapid detection of an occurrence of a stroke event

Device including biosensor and holder

BIOMARKERS FOR THE PROGNOSIS OF ISCHEMIC STROKE

BIOMARKER ASSAY OF NEUROLOGICAL CONDITION

Diagnostic marker for treatment of cerebral ischemia

Use of GFAP for identification of intracerebral hemorrhage

Blood biomarker for early blood brain barrier disruption in ischemic stroke

Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)

Methods for treatment of cardiovascular disease

1L1RL-1 as a cardiovascular disease marker and therapeutic target

NEURAL SPECIFIC S100B FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION

Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity C-reactive protein

Method for detecting injury to the brain

Method of Determining Hypoxia

Chronic Traumatic Encephalopathy in Blast-Exposed Individuals

Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury

Immobilized protein system for rapid and enhanced multiplexed diagnostics

SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion

BIOMARKERS OF BRAIN INJURY

Biomarkers for diagnosing ischemia

Device and methods for the immunological identification of cerebrospinal fluid

Oxidized cardiolipin as a pro-inflammatory factor

Blood biomarker for early blood brain barrier disruption in ischemic stroke

NT-proANP and NT-proBNP for the diagnosis of stroke

Biomarkers of brain injury

Method for determining the risk of cardiovascular events using IGFBP fragments

Device and methods for the immunological identification of cerebrospinal fluid

Therapy for subarachnoid hemorrhage and ischemia

Use of endogenous antioxidant proteins in the treatment of stroke

Methods of identifying modulators of GPR17

Composition comprising an angiopoietin-4 fragment

Novel Biomarker Indicative of Ischemic Brain Injury and Its Use

Reporter system for high throughput screening of compounds and uses thereof

BIOMARKERS FOR THE DIAGNOSIS OF LACUNAR STROKE

Method for Evaluating the Cure Level of Stroke

Biomarkers for sensitive detection of statin-induced muscle toxicity

METHOD OF DIAGNOSING MILD TRAUMATIC BRAIN INJURY

Method and compositions for treating stroke with fever

Method of reducing side effects associated with administration of tissue plasminogen activator (tPA)

PROCALCITONIN FOR THE PROGNOSIS OF ADVERSE EVENTS

Method of Detecting Major In-Hospital Ischemic Complications and Predicting Length of Stay at an Intensive Care Unit

NMDAR BIOMARKERS FOR DIAGNOSING AND TREATING CEREBRAL ISCHEMIA

BIOMARKERS FOR DIAGNOSIS OF STROKE AND ITS CAUSES

Assays for Differentiating between Ischemic and Hemorrhagic Stroke in a Human Patient

BIOMARKERS FOR STROKE

Method for the in vitro diagnosis of stroke

BIOMARKERS FOR DIAGNOSIS OF TRANSIENT ISCHEMIC ATTACKS

Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles

Method for the in vitro diagnosis of stroke

DIFFERENTIAL DIAGNOSTIC BIOMARKERS OF STROKE MIMICKING CONDITIONS AND METHODS OF USE THEREOF

Methods for treatment of cardiovascular disease

Compositions and methods for predicting cardiovascular events

IL1RL-1 as a cardiovascular disease marker and therapeutic target

Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor

Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands

IMMUNOASSAYS FOR AUTOANTIBODIES IN CARDIOVASCULAR DISEASES

In Vitro Model of Focal Ischemia

Method of treating neurological conditions with cardiac glycoside

BIOMARKER DETECTION PROCESS AND ASSAY OF NEUROLOGICAL CONDITION

Prognosis Biomarker for Evaluating the Cure Level of Stroke Patient and a Method thereof

Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack

PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY

METHODS FOR DETECTING MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS

Device and methods for the immunological identification of cerebrospinal fluid

Endothelial monocyte activation polypeptide II, a biomarker for use in diagnosis and treatment of brain injury

Biomarkers of Hemorrhagic Shock

METHOD OF PREVENTING AND TREATING ACUTE BRAIN PATHOLOGIES

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Diagnostic methods for acute ischemic disease using activated hepcidin as an indicator

COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITY

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

PLASMINOGEN ACTIVATOR INHIBITOR AMELIORATION OF NEWBORN HYPOXIC ISCHEMIC BRAIN INJURY

Methods for identifying GLP-1 secretagogues

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

CD36 MODULATION AND USES THEREOF

Methods of Identifying Improved NMDA Receptor Antagonists

Methods of detection of factor XIa and tissue factor

Methods of treating stroke and traumatic brain injury using humanized AQC2 anti-VLA-1 antibodies

TREATMENT AND PREVENTION OF ISCHEMIC BRAIN INJURY

NMDAR Biomarkers for Diagnosing and Treating Cerebral Ischemia

ISCHEMIC BIOMARKERS AND THEIR USE TO PREDICT ADVERSE NEUROLOGICAL EVENTS FROM SURGERY

METHOD OF DETECTING CEREBRAL STROKE OR ASYMPTOMATIC CEREBRAL INFARCTION USING ACROLEIN, INTERLEUKIN-6 AND CRP CONTENTS, POLYAMINE OXIDASE ACTIVITY OR POLYAMINE OXIDASE PROTEIN CONTENT AND SUBJECT'S AGE AS INDICATORS

IL1RL-1 as a cardiovascular disease marker and therapeutic target

BIOMARKERS FOR NEUROLOGICAL CONDITIONS

Compositions and Methods for Modulation of ADAMTS13 Activity

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

Development of sensitive FRET sensors and methods of using the same

A NEUROGLOBIN ENZYME-LINKED IMMUNOSORBENT ASSAY KIT AND THE USE OF IT

Assay Device and Method

METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID

A Method And A Kit For Diagnosing Type 2 Diabetes, Metabolic Syndrome, Sub Clinical Atherosclerosis, Myocardial Infarct, Stroke Or Clinical Manifestations Of Diabetes

Method of Differentially Diagnosing Dementias

Method and kit for detecting condition in patient with disturbance of consciousness

Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathways

Methods for diagnosis of cardiovascular disease

Methods for diagnosing cerebrovascular events based on NR2 peptides

Biological markers for longevity and diseases and uses thereof

Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)

Endothelial-monocyte activating polypeptide II, a biomarker for use in diagnosis of brain injury

Serine and threoninephosphorylation sites

Novel GPCR and methods of use of the same

Method of Diagnosing Cerebral Infarction

Targets for Detection of Ischemia

Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient

Method of diagnosing apoplectic stroke/asymptomatic brain infarction using acrolein content

Method of determining hypoxia

Ischemic Biomarkers and their Use to Predict Adverse Neurological Events from Surgery

ASSESSING RISK OF CEREBROVASCULAR THROMBOSIS BY MEASURING C4D

USE OF BNP-TYPE PEPTIDES FOR THE STRATIFICATION OF THERAPY WITH ERYTHROPOIETIC STIMULATING AGENTS

Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof

Compositions and Methods of Use for a Fibroblast Growth Factor

MARKERS FOR DIFFERENTIAL DIAGNOSIS AND METHODS OF USE THEREOF

Diagnostic markers for ischemia

Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator

Assessing risk of cerebrovascular thrombosis by measuring C4d on platelets

Diagnostic method for stroke

Multidimensional mass spectrometry or serum and celluar lipids directly from biologic extracts

Methods of treating cancer, arthritis and/or diabetes with angiopoietins

Diagnostic assay for stroke

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level